ADMA Biologics Inc
NASDAQ:ADMA
Income Statement
Earnings Waterfall
ADMA Biologics Inc
Revenue
|
258.2m
USD
|
Cost of Revenue
|
-169.3m
USD
|
Gross Profit
|
88.9m
USD
|
Operating Expenses
|
-67.3m
USD
|
Operating Income
|
21.6m
USD
|
Other Expenses
|
-49.9m
USD
|
Net Income
|
-28.2m
USD
|
Income Statement
ADMA Biologics Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
3
N/A
|
4
+25%
|
5
+20%
|
5
+6%
|
6
+22%
|
6
-1%
|
6
-3%
|
6
+8%
|
7
+17%
|
8
+8%
|
9
+12%
|
10
+12%
|
11
+9%
|
11
+4%
|
12
+10%
|
14
+15%
|
23
+62%
|
24
+6%
|
25
+5%
|
25
-2%
|
17
-32%
|
16
-3%
|
18
+12%
|
21
+16%
|
29
+37%
|
36
+23%
|
37
+3%
|
40
+8%
|
42
+5%
|
48
+14%
|
58
+21%
|
69
+18%
|
81
+18%
|
94
+16%
|
110
+17%
|
130
+19%
|
154
+18%
|
182
+18%
|
208
+14%
|
234
+13%
|
258
+10%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(2)
|
(2)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(5)
|
(5)
|
(6)
|
(6)
|
(7)
|
(10)
|
(19)
|
(29)
|
(40)
|
(45)
|
(43)
|
(42)
|
(39)
|
(40)
|
(39)
|
(40)
|
(47)
|
(50)
|
(54)
|
(61)
|
(62)
|
(68)
|
(76)
|
(80)
|
(87)
|
(95)
|
(106)
|
(119)
|
(134)
|
(151)
|
(162)
|
(169)
|
|
Gross Profit |
1
N/A
|
1
+31%
|
2
+22%
|
2
+7%
|
2
+24%
|
2
-1%
|
2
-2%
|
2
+11%
|
3
+22%
|
3
+8%
|
4
+13%
|
4
+13%
|
4
+8%
|
4
+3%
|
3
-42%
|
(5)
N/A
|
(6)
-24%
|
(16)
-144%
|
(20)
-26%
|
(18)
+8%
|
(25)
-40%
|
(23)
+9%
|
(22)
+5%
|
(18)
+19%
|
(10)
+42%
|
(11)
-7%
|
(13)
-16%
|
(14)
-7%
|
(19)
-41%
|
(14)
+26%
|
(9)
+33%
|
(7)
+21%
|
1
N/A
|
7
+447%
|
15
+134%
|
25
+60%
|
35
+43%
|
48
+36%
|
57
+19%
|
72
+26%
|
89
+23%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(16)
|
(19)
|
(18)
|
(19)
|
(18)
|
(16)
|
(16)
|
(17)
|
(18)
|
(20)
|
(22)
|
(22)
|
(22)
|
(24)
|
(25)
|
(28)
|
(32)
|
(36)
|
(36)
|
(37)
|
(35)
|
(34)
|
(33)
|
(33)
|
(31)
|
(34)
|
(38)
|
(42)
|
(46)
|
(48)
|
(51)
|
(54)
|
(60)
|
(65)
|
(67)
|
(71)
|
(75)
|
(73)
|
(74)
|
(71)
|
(67)
|
|
Selling, General & Administrative |
(7)
|
(7)
|
(8)
|
(8)
|
(9)
|
(9)
|
(9)
|
(11)
|
(11)
|
(12)
|
(12)
|
(12)
|
(14)
|
(17)
|
(20)
|
(22)
|
(25)
|
(26)
|
(26)
|
(28)
|
(30)
|
(30)
|
(30)
|
(30)
|
(28)
|
(30)
|
(33)
|
(36)
|
(39)
|
(43)
|
(47)
|
(50)
|
(55)
|
(61)
|
(63)
|
(67)
|
(70)
|
(69)
|
(69)
|
(66)
|
(63)
|
|
Research & Development |
(9)
|
(12)
|
(10)
|
(11)
|
(10)
|
(7)
|
(6)
|
(7)
|
(7)
|
(8)
|
(10)
|
(9)
|
(8)
|
(7)
|
(5)
|
(5)
|
(6)
|
(6)
|
(6)
|
(6)
|
(4)
|
(4)
|
(3)
|
(2)
|
(2)
|
(3)
|
(4)
|
(5)
|
(6)
|
(5)
|
(5)
|
(4)
|
(4)
|
(3)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(3)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(2)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
(15)
N/A
|
(18)
-17%
|
(16)
+7%
|
(17)
-3%
|
(16)
+5%
|
(14)
+15%
|
(13)
+1%
|
(15)
-12%
|
(16)
-3%
|
(17)
-11%
|
(18)
-7%
|
(18)
+5%
|
(17)
+1%
|
(19)
-10%
|
(22)
-15%
|
(33)
-49%
|
(38)
-17%
|
(51)
-33%
|
(56)
-10%
|
(55)
+1%
|
(60)
-9%
|
(57)
+6%
|
(55)
+4%
|
(50)
+9%
|
(41)
+17%
|
(45)
-9%
|
(51)
-13%
|
(56)
-9%
|
(65)
-17%
|
(62)
+4%
|
(61)
+2%
|
(61)
-1%
|
(58)
+5%
|
(58)
+1%
|
(52)
+11%
|
(47)
+10%
|
(39)
+15%
|
(25)
+35%
|
(17)
+34%
|
1
N/A
|
22
+1 502%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(4)
|
(5)
|
(5)
|
(5)
|
(5)
|
(6)
|
(7)
|
(8)
|
(9)
|
(10)
|
(11)
|
(12)
|
(12)
|
(13)
|
(13)
|
(13)
|
(13)
|
(15)
|
(17)
|
(19)
|
(22)
|
(23)
|
(24)
|
(23)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
0
|
(10)
|
(10)
|
(10)
|
(10)
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
(7)
|
(7)
|
(7)
|
(7)
|
0
|
0
|
0
|
(26)
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
12
|
12
|
12
|
12
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(1)
|
(0)
|
|
Pre-Tax Income |
(16)
N/A
|
(18)
-17%
|
(17)
+5%
|
(18)
-4%
|
(17)
+3%
|
(15)
+13%
|
(16)
-5%
|
(18)
-11%
|
(18)
-3%
|
(19)
-5%
|
(20)
-7%
|
(20)
+4%
|
(20)
+0%
|
(21)
-10%
|
(24)
-14%
|
(35)
-44%
|
(44)
-24%
|
(55)
-26%
|
(61)
-10%
|
(61)
+0%
|
(66)
-8%
|
(61)
+7%
|
(59)
+3%
|
(56)
+6%
|
(48)
+13%
|
(54)
-13%
|
(61)
-13%
|
(67)
-9%
|
(76)
-13%
|
(75)
+1%
|
(74)
+2%
|
(74)
-1%
|
(72)
+4%
|
(78)
-9%
|
(73)
+7%
|
(70)
+4%
|
(66)
+6%
|
(48)
+28%
|
(40)
+15%
|
(23)
+43%
|
(28)
-24%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(16)
|
(18)
|
(17)
|
(18)
|
(17)
|
(15)
|
(15)
|
(17)
|
(18)
|
(19)
|
(20)
|
(20)
|
(20)
|
(21)
|
(24)
|
(35)
|
(44)
|
(55)
|
(61)
|
(61)
|
(66)
|
(61)
|
(59)
|
(56)
|
(48)
|
(54)
|
(61)
|
(67)
|
(76)
|
(75)
|
(74)
|
(74)
|
(72)
|
(78)
|
(73)
|
(70)
|
(66)
|
(48)
|
(40)
|
(23)
|
(28)
|
|
Net Income (Common) |
(16)
N/A
|
(18)
-17%
|
(17)
+5%
|
(18)
-4%
|
(17)
+6%
|
(15)
+14%
|
(15)
-5%
|
(17)
-11%
|
(18)
-6%
|
(19)
-5%
|
(20)
-7%
|
(20)
+4%
|
(20)
+0%
|
(21)
-10%
|
(24)
-14%
|
(35)
-44%
|
(44)
-24%
|
(55)
-26%
|
(61)
-10%
|
(61)
+0%
|
(66)
-8%
|
(61)
+7%
|
(59)
+3%
|
(56)
+6%
|
(48)
+13%
|
(54)
-13%
|
(61)
-13%
|
(67)
-9%
|
(76)
-13%
|
(75)
+1%
|
(74)
+2%
|
(74)
-1%
|
(72)
+4%
|
(78)
-9%
|
(73)
+7%
|
(70)
+4%
|
(66)
+6%
|
(48)
+28%
|
(40)
+15%
|
(23)
+43%
|
(28)
-24%
|
|
EPS (Diluted) |
-1.82
N/A
|
-1.95
-7%
|
-1.85
+5%
|
-1.93
-4%
|
-1.81
+6%
|
-1.47
+19%
|
-1.42
+3%
|
-1.58
-11%
|
-1.73
-9%
|
-1.79
-3%
|
-1.67
+7%
|
-1.51
+10%
|
-1.61
-7%
|
-1.66
-3%
|
-1.48
+11%
|
-1.37
+7%
|
-1.91
-39%
|
-1.21
+37%
|
-1.42
-17%
|
-1.3
+8%
|
-1.45
-12%
|
-1.31
+10%
|
-1.13
+14%
|
-0.93
+18%
|
-0.89
+4%
|
-0.73
+18%
|
-0.71
+3%
|
-0.76
-7%
|
-0.88
-16%
|
-0.64
+27%
|
-0.57
+11%
|
-0.55
+4%
|
-0.51
+7%
|
-0.39
+24%
|
-0.37
+5%
|
-0.37
N/A
|
-0.33
+11%
|
-0.21
+36%
|
-0.2
+5%
|
-0.11
+45%
|
-0.13
-18%
|